DVY vs IBB
iShares Select Dividend ETF vs iShares Biotechnology ETF
- • DVY has the lower expense ratio at 0.38% vs 0.44% for IBB.
- • DVY pays a higher dividend yield (3.38%).
Side-by-side metrics
| Metric | DVY | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.38% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.38% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $22.86B | $7.95B |
YTD return | 9.91% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.64 | 0.74 |
P/E ratio | 15.44 | 23.72 |
Last price | $152.45 | $170.10 |
Inception | — | — |
Issuer | iShares | iShares |
DVY top holdings
| MO | Altria Group Inc | 2.29% |
| PFE | Pfizer Inc | 2.22% |
| TROW | T. Rowe Price Group Inc | 2.02% |
| VZ | Verizon Communications Inc | 1.85% |
| PRU | Prudential Financial Inc | 1.84% |
| OKE | ONEOK Inc | 1.83% |
| HPQ | HP Inc | 1.61% |
| EIX | Edison International | 1.53% |
| LYB | LyondellBasell Industries NV Class A | 1.53% |
| GIS | General Mills Inc | 1.52% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About DVY
DVY (iShares Select Dividend ETF) is 100 high-dividend-yielding US stocks. Managed by iShares, the fund carries $22.9B in assets under management, an expense ratio of 0.38%, a dividend yield of 3.38%. Its largest holding is Altria Group Inc (MO), which represents 2.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.4%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.